Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara

BACKGROUND: A human immunodeficiency virus (HIV) vaccine that limits disease and transmission is urgently needed. This clinical trial evaluated the safety and immunogenicity of an HIV vaccine that combines a plasmid-DNA priming vaccine and a modified vaccinia virus Ankara (MVA) boosting vaccine. MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Sandström, Eric, Nilsson, Charlotta, Hejdeman, Bo, Bråve, Andreas, Bratt, Göran, Robb, Merlin, Cox, Josephine, VanCott, Thomas, Marovich, Mary, Stout, Richard, Aboud, Said, Bakari, Muhammad, Pallangyo, Kisali, Ljungberg, Karl, Moss, Bernard, Earl, Patricia, Michael, Nelson, Birx, Deborah, Mhalu, Fred, Wahren, Britta, Biberfeld, Gunnel
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4793972/
https://ncbi.nlm.nih.gov/pubmed/18808335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/592507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados